A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer’s disease brain | bioRxiv

A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer’s disease brain | bioRxiv

A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer’s disease brain

Ebru Ercan-Herbst, David C. Schöndorf, Annika Behrendt, Bernd Klaus,  View ORCID ProfileBorja Gomez Ramos, Christian Weber,  View ORCID ProfileDagmar E. Ehrnhoefer

doi: https://doi.org/10.1101/594820

This article is a preprint and has not been certified by peer review [what does this mean?].